-
Sorrento's (SRNEQ) Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms t
-
Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders
-
Scilex Holding Company Announces Postponement of Annual Meeting of Stockholders
-
Sorrento's (SRNEQ) Bankruptcy Court Requires Brokerages to Provide Information Related to Scilex Common Stock
-
Sorrento Therapeutics (SRNE) Granted Court Approval for $75M Financing in Chapter 11 Case
-
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case
-
Sorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)
-
Sorrento Therapeutics (SRNE) Receives Court Approval for "First Day" Employee Wages and Cash Management Motions
-
Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions
-
Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.
-
Sorrento Therapeutics (SRNE) commences voluntary proceedings under Chapter 11 of the United States Bankruptcy Code
-
Pre-Open Stock Movers 05/16: (NSPH) (ANAC) (TPUB) Higher; (BBEP) (ADRO) (TRVN) Lower (mor

